Diagnostic Approach for Ground Glass Nodules on Chest CT

Initial Imaging Protocol

The American College of Radiology recommends obtaining a dedicated thin-section chest CT without IV contrast using 1.0-1.5mm contiguous slices with multiplanar reconstructions as the immediate next step for adults aged 40-80 with smoking history or environmental toxin exposure presenting with ground glass nodules (GGNs) on chest CT, followed by risk-stratified surveillance based on nodule size and characteristics 1, 2, 3
All chest CTs evaluating GGNs must be reconstructed with thin sections ≤1.5mm (typically 1.0mm) to enable accurate characterization of ground-glass components and avoid volume averaging that obscures critical features 1, 2, 3
Routine coronal and sagittal reconstructed series should be obtained and archived, as these facilitate distinction between nodules and scars and improve nodule localization 2, 3
Use low-dose technique with volumetric CT dose index (CTDIvol) ≤3 mGy in standard-size patients to minimize radiation exposure during surveillance 2, 3
IV contrast adds no diagnostic value for nodule identification, characterization, or stability assessment and should not be used 1, 4, 5, 3

Immediately obtain and review all available prior chest imaging to establish stability, as 2-year documented stability essentially confirms benignity and eliminates need for further workup 1, 3, 6
If thick sections were used on prior studies, obtain new thin-section baseline for accurate future comparison 2, 3

Pure GGNs ≤5mm require no further evaluation or follow-up due to extremely low malignancy risk 5, 3, 7
Pure GGNs >5mm to ≤30mm require follow-up CT at 6-12 months to confirm persistence, and if persistent, continue surveillance CT every 2 years for minimum 5 years total 3, 7
Part-solid nodules carry significantly higher malignancy risk than pure GGNs, even when small, and require more aggressive surveillance 3, 7
Part-solid nodules require CT surveillance at 3 months, 12 months, and 24 months regardless of size 3, 7

High-risk features include age ≥60 years, heavy smoking history, upper lobe location, nodule size >10mm, spiculated margins, and family history of lung cancer 8, 3, 7
Low-risk features include age <50 years, never-smoker or minimal smoking history, lower lobe location, and smooth margins 8, 3

Diffuse, central, laminated, or popcorn calcification patterns are definitively benign and require no surveillance 1, 3, 7
Macroscopic fat indicates benign hamartoma 1, 2, 3
Typical perifissural nodules represent intrapulmonary lymph nodes and require no follow-up even if >6mm 8, 7

Documented growth with volume increase ≥25% or volume doubling time <400 days requires tissue diagnosis 3, 7
Part-solid nodule with solid component ≥6mm requires tissue diagnosis 3, 7
Development of new solid component within previously pure GGN requires tissue diagnosis 3
Patient preference after informed discussion of risks/benefits requires tissue diagnosis 7

CT-guided percutaneous biopsy is usually appropriate for peripheral GGNs, with 90-95% sensitivity and 99% specificity, though pneumothorax occurs in 19-25% of cases 9, 7
Bronchoscopy with advanced techniques achieves 65-89% diagnostic yield for nodules >2cm and lower pneumothorax risk 7
Transthoracic needle biopsy has important limitations for pure ground-glass lesions due to inadequate sampling and false-negative results 8, 9
Video-assisted thoracoscopic surgery provides definitive diagnosis approaching 100% accuracy and offers therapeutic benefit if malignancy confirmed 9, 7

Do not use thick-slice CT (>1.5mm sections), as this causes volume averaging that obscures ground-glass components and may misclassify part-solid nodules as pure GGNs 1, 2, 3
Do not use chest radiography for follow-up, as most nodules <1cm are invisible on plain films and radiographs lack resolution for adequate characterization 4, 5, 3
Do not order PET-CT for nodules <8mm, as limited spatial resolution makes PET unreliable for small nodules and produces false-negatives in well-differentiated adenocarcinomas and bronchioloalveolar carcinomas 9, 3, 7

Multiple bilateral GGNs of similar size without mediastinal lymphadenopathy likely represent synchronous separate primary lung cancers rather than metastases 10
Each lesion should be staged separately with distinct T descriptor, with number of lesions indicated in parentheses 10
Patients with multifocal GGN adenocarcinoma have better prognosis with less lymph node involvement than conventional adenocarcinoma 10

Integrate smoking cessation counseling immediately for all current smokers, as this clearly reduces mortality independent of nodule management 3
Provide written materials, telephone hotline access, and consider nicotine replacement therapy or pharmacologic treatment 3